Market stats UK Register to read

5 Characteristics of the UK Polynucleotide market

UK polynucleotide providers doubled to around 3,000 in March 2025. The category is propagating through existing injectable portfolios: nearly all also offer botulinum toxin and dermal fillers.

By Rare.Monitor analyst team Published 25 April 2025 Last updated 12 May 2026

April 2025 / Aesthetics / UK

Medical AestheticsPolynucleotides

3,000

UK providers actively offering polynucleotide treatments

Doubled in 12 months

Source: Rare.Monitor, March 2025. UK polynucleotide providers.

RARE

UK providers actively offering polynucleotide treatments. Hyaluronic acid dermal fillers, biostimulators and other regenerative aesthetics brands are tracked in separate Rare.Monitor analyses.

Registered access

Read the full report

We use your details to send relevant research and insights. Unsubscribe at any time. See our privacy policy.

Already have an account? Sign in

Free. Takes 30 seconds.  ·  Rare.Monitor tracks over 230,000 UK health, wellness and beauty places  ·  MRS · ABPI · BHBIA member

Key findings

Rare.Monitor identified around 3,000 UK providers actively offering polynucleotide treatments in March 2025, approximately double the position twelve months earlier. The category is highly fragmented: the top 10 providers deliver around 5% of polynucleotide treatments. 98% of polynucleotide providers also offer botulinum toxin and 97% also offer dermal fillers.

Related content

Market Stats cover for Ireland Medical Aesthetics Market: Top Treatments Offered, April 2026. 84% of Republic of Ireland medical aesthetics clinics offer botulinum toxin. Rare.Monitor audit of 504 ROI clinics. Full treatment portfolio analysis with free registration.
Market stats

Ireland Medical Aesthetics Market: Top Treatments Offered, April 2026

May 2026 / Medical Aesthetics / ROI

Register to read ROI
Market Stats cover for UK Medical Aesthetics: Top Treatments Offered, April 2026. 86% of UK medical aesthetics clinics offer botulinum toxin, with dermal fillers (71%) and skin boosters (56%) completing the dominant injectable trio. Full treatment portfolio analysis with free registration.
Market stats

UK Medical Aesthetics Market: Top Treatments Offered, April 2026

April 2026 / Medical Aesthetics / UK

Register to read UK
Brand analysis cover for UK Medical-Grade Skincare, May 2026. Obagi leads UK clinic mentions at 44.7%, based on Rare.Monitor audit of 14,511 UK clinics offering medical-grade skincare. The full top 10 ranking and parent manufacturer for every brand is available with free registration.
Brand amplification

Brand analysis: UK Medical-Grade Skincare, May 2026

May 2026 / Medical Aesthetics / UK

Register to read UK

Reference

More on this analysis

Rare.Monitor

See what Rare.Monitor would do for your numbers.

Book a demo